IND Swift Laboratories P/FCF

Que fait IND Swift Laboratories ? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories est l'une des entreprises les plus populaires sur Eulerpool.